NORTH CHICAGO, Ill., Feb. 19, 2015 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 4 percent from $0.49 per share to $0.51 per share.
The cash dividend is payable May 15, 2015 to stockholders of record at the close of business on April 15, 2015.
Since the company's inception in 2013, AbbVie has increased its dividend by 28 percent. AbbVie was named to the 2015 S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.